Abirateron Fresenius Kabi 500 mg film-coat. tabl.
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Abiraterone Acetate 500 mg
Available from:
Fresenius Kabi SA-NV
ATC code:
L02BX03
Pharmaceutical form:
Film-coated tablet
Administration route:
Oral use
Therapeutic area:
Abiraterone
Product summary:
CTI Extended: 587333-01
Authorization status:
Commercialised: No
Authorization date:
2021-07-02
